ArticleBiomedicines2025

Neuropilin-1: A Conserved Entry Receptor for SARS-CoV-2 and a Potential Therapeutic Target.

Vivany Maydel Sierra-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.